Advertisement
Journal Home
Search for

Articles in Press

Return to articles in press list

Appearance of primary lymphoid malignancies on lymphotropic nanoparticle-enhanced magnetic resonance imaging using ferumoxtran-10

Anuradha Saokarab, Michael S. Geeab, Tina IslamabCorresponding Author Informationemail address, Peter R. Muellerb, Mukesh G. Harisinghaniab

Received 28 August 2009; accepted 28 September 2009. published online 15 January 2010.
Corrected Proof

Abstract 

Patients with pathologically confirmed lymphoma/leukemia were retrospectively identified from a large single-institution phase III clinical trial with ferumoxtran-10. Five (2.3%) of 220 patients had lymphoid malignancies involving lymph nodes. A subset of patients (n=27) with biopsy-proven nodal metastases from genitourinary or breast cancer was selected as control group. Ferumoxtran-10 enhancement patterns and signal-to-noise ratios of lymph nodes involved by metastases and lymphoid malignancy were assessed. Like nodal metastases, nodes involved by lymphoid malignancies demonstrate persistent high T2*-signal intensity on lymphotropic nanoparticle-enhanced magnetic resonance imaging.

a Center for Molecular Imaging Research, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA

b Department of Radiology, Division of Abdominal Imaging and Intervention, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA

Corresponding Author InformationCorresponding author. Center for Molecular Imaging Research, Department of Radiology, Division of Abdominal Imaging and Intervention, Boston, MA 02114, USA. Tel.: +1 617 724 4266; fax: +1 617 726 4891.

PII: S0899-7071(09)00313-1

doi:10.1016/j.clinimag.2009.09.008

Advertisement